BETH ISRAEL DEACONESS MEDICAL CENTER
Navigating Pathways of Innate Immunity and Epigenetic Memory in Checkpoint Immunotherapy
Navigating Pathways of Innate Immunity and Epigenetic Memory in Checkpoint Immunotherapy is a funding opportunity from BETH ISRAEL DEACONESS MEDICAL CENTER, up to 846982, closing July 31, 2032.
Jul 31, 2032
(2192d left)Overview
My laboratory has been at the vanguard of the discovery of costimulatory molecules and checkpoint inhibitors and their role in cancer. The field of cancer immunotherapy has mainly focused on the impact of immune checkpoints (IC) and their blockade on the activation of tumor-associated T cells. Although antigen…